Exact Mass: 375.3137

Exact Mass Matches: 375.3137

Found 82 metabolites which its exact mass value is equals to given mass value 375.3137, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Adrenoyl ethanolamide

(7Z,10Z,13Z,16Z)-N-(2-hydroxyethyl)docosa-7,10,13,16-tetraenamide

C24H41NO2 (375.3137)


Adrenoyl ethanolamide is a N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation has been attributed a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. N-oleoylethanolamine is an inhibitor of the sphingolipid signaling pathway, via specific ceramidase inhibition (ceramidase converts ceramide to sphingosine). N-oleoylethanolamine blocks the effects of TNF- and arachidonic acid on intracellular Ca concentration. (PMID: 12692337, 12056855, 12560208, 11997249) [HMDB] Adrenoyl ethanolamide is a N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation has been attributed a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. N-oleoylethanolamine is an inhibitor of the sphingolipid signaling pathway, via specific ceramidase inhibition (ceramidase converts ceramide to sphingosine). N-oleoylethanolamine blocks the effects of TNF- and arachidonic acid on intracellular Ca concentration. (PMID: 12692337, 12056855, 12560208, 11997249).

   

N-(2,4-Eicosadienoyl)piperidine

(2Z,4E)-1-(piperidin-1-yl)icosa-2,4-dien-1-one

C25H45NO (375.3501)


N-(2,4-Eicosadienoyl)piperidine is an alkaloid from Piper retrofractum (Javanese long pepper

   

N-(2,14-Eicosadienoyl)piperidine

(2E,14E)-1-(piperidin-1-yl)icosa-2,14-dien-1-one

C25H45NO (375.3501)


N-(2,14-Eicosadienoyl)piperidine is an alkaloid from Piper retrofractum (Javanese long pepper

   

N-Arachidonoyl Alanine

2-(icosa-5,8,11,14-tetraenamido)propanoic acid

C23H37NO3 (375.2773)


N-arachidonoyl alanine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Alanine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Alanine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Alanine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Myristoyl Phenylalanine

2-[(1-Hydroxytetradecylidene)amino]-3-phenylpropanoate

C23H37NO3 (375.2773)


N-myristoyl phenylalanine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Phenylalanine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Phenylalanine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Phenylalanine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Docosatetraenylethanolamide

N-(2-Hydroxyethyl)docosa-7,10,13,16-tetraenimidate

C24H41NO2 (375.3137)


   

Calyciphylline O

Calyciphylline O

C23H37NO3 (375.2773)


   

Pachyaximine B

Pachyaximine B

C24H41NO2 (375.3137)


   

3-Eicosyl-1H-pyrrole-2-carboxaldehyde

3-Eicosyl-1H-pyrrole-2-carboxaldehyde

C25H45NO (375.3501)


   

caldaphnidine L

caldaphnidine L

C23H37NO3 (375.2773)


   

methyl 7-hydroxyhomodaphniphyllate|rel-(3aR,4S,4aS,5R,8S,8aR,8bS,9S,10S)-octahydro-9-hydroxy-8-methyl-5-(1-methylethyl)-4,8,3a-[1,2,4]butanetriylcyclopent[b]indole-8a(4aH)-propanoic acid methyl ester

methyl 7-hydroxyhomodaphniphyllate|rel-(3aR,4S,4aS,5R,8S,8aR,8bS,9S,10S)-octahydro-9-hydroxy-8-methyl-5-(1-methylethyl)-4,8,3a-[1,2,4]butanetriylcyclopent[b]indole-8a(4aH)-propanoic acid methyl ester

C23H37NO3 (375.2773)


   

N-(3-Methoxybenzyl)Palmitamide

N-(3-Methoxybenzyl)Palmitamide

C24H41NO2 (375.3137)


   

methyl 17-hydroxyhomodaphniphyllate

methyl 17-hydroxyhomodaphniphyllate

C23H37NO3 (375.2773)


   
   

NA 24:4;O

N-(1,1-dimethy-2-hydroxy-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C24H41NO2 (375.3137)


N-(3-Methoxybenzyl)palmitamide is a natural product found in Lepidium meyenii with data available. N-(3-Methoxybenzyl)Palmitamide is a promising inhibitor of FAAH for the treatment of pain, inflammation and CNS degenerative disorders[1]. N-(3-Methoxybenzyl)Palmitamide is a promising inhibitor of FAAH for the treatment of pain, inflammation and CNS degenerative disorders[1].

   

N-(1,1-dimethyl-2-hydroxy-ethyl)arachidonoylamide

N-(1,1-dimethy-2-hydroxy-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C24H41NO2 (375.3137)


   

N-ethyl N-(2-hydroxy-ethyl)arachidonoylamide

N-ethyl-N-(2-hydroxy-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C24H41NO2 (375.3137)


   

alpha,alpha-dimethyl anandamide

N-(2,2-dimethy-5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine

C24H41NO2 (375.3137)


   

N-(5Z,8Z,11Z,14Z-docosatetraenoyl)-ethanolamine

N-(5Z,8Z,11Z,14Z-docosatetraenoyl)-ethanolamine

C24H41NO2 (375.3137)


   

N-Arachidonoyl-L-Alanine

N-(1-oxo-5Z,8Z,11Z,14Z-eicosatetraenyl)-L-alanine

C23H37NO3 (375.2773)


An N-acyl-L-alanine resulting from the formal condensation of the amino group of L-alanine with the carboxy group of arachidonic acid.

   

N-arachidonoyl alanine

N-(5Z,8Z,11Z,15Z-eicosatetraenoyl)-alanine

C23H37NO3 (375.2773)


   

5,8,11,14-all-cis-docosatetraenoylethanolamine

N-(5Z,8Z,11Z,14Z-docosatetraenoyl)-ethanolamine

C24H41NO2 (375.3137)


   

N-(2,4-Eicosadienoyl)piperidine

(2Z,4E)-1-(piperidin-1-yl)icosa-2,4-dien-1-one

C25H45NO (375.3501)


   

2,14-Eicosadienoic acid piperidide

(2E,14E)-1-(piperidin-1-yl)icosa-2,14-dien-1-one

C25H45NO (375.3501)


   

NA 23:5;O2

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl) alanine

C23H37NO3 (375.2773)


   

NAE 22:4

N-(2,2-dimethy-5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine

C24H41NO2 (375.3137)


   

sodium (Z)-N-methyl-N-(1-oxo-9-octadecenyl)aminoacetate

sodium (Z)-N-methyl-N-(1-oxo-9-octadecenyl)aminoacetate

C21H38NNaO3 (375.2749)


   

PEG-2 OLEAMINE HYDROFLUORIDE

PEG-2 OLEAMINE HYDROFLUORIDE

C22H46FNO2 (375.3512)


   

Daphnezomine B

Daphnezomine B

C23H37NO3 (375.2773)


   

hydrogen ionophore iv

hydrogen ionophore iv

C24H41NO2 (375.3137)


   
   

sodium N-methyl-N-(1-oxo-9-octadecenyl)aminoacetate

sodium N-methyl-N-(1-oxo-9-octadecenyl)aminoacetate

C21H38NNaO3 (375.2749)


   

Sodium 1-palmitoyl-L-prolinate

Sodium 1-palmitoyl-L-prolinate

C21H38NNaO3 (375.2749)


   

N-Myristol-L-phenylalanine

N-Myristol-L-phenylalanine

C23H37NO3 (375.2773)


   

Octadecanamide,N-(4-hydroxyphenyl)-

Octadecanamide,N-(4-hydroxyphenyl)-

C24H41NO2 (375.3137)


   

Glycerides, tallow mono-, hydrogenated

Glycerides, tallow mono-, hydrogenated

C21H43O5- (375.311)


   

3-Picolinyl stearate

3-Picolinyl stearate

C24H41NO2 (375.3137)


   

(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate

(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate

C24H39O3- (375.2899)


   

Isolithocholate

Isolithocholate

C24H39O3- (375.2899)


A bile acid anion that is the conjugate base of isolithocholic acid, obtained by deprotonation of the carboxy group. The 3beta-hydroxy epimer of lithocholate. It is the major microspecies at pH 7.3.

   

(7E,10E,13E,16E)-N-(2-hydroxyethyl)docosa-7,10,13,16-tetraenamide

(7E,10E,13E,16E)-N-(2-hydroxyethyl)docosa-7,10,13,16-tetraenamide

C24H41NO2 (375.3137)


   

2-[[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]amino]propanoic acid

2-[[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]amino]propanoic acid

C23H37NO3 (375.2773)


   

(8S)-2-hexadec-6-enoyl-1-hydroxy-5,6,7,8-tetrahydropyrrolizin-3-one

(8S)-2-hexadec-6-enoyl-1-hydroxy-5,6,7,8-tetrahydropyrrolizin-3-one

C23H37NO3 (375.2773)


   

Cer 8:0;3O/12:0;(2OH)

Cer 8:0;3O/12:0;(2OH)

C20H41NO5 (375.2985)


   

(10Z,13Z,16Z,19Z)-N-(2-hydroxyethyl)docosa-10,13,16,19-tetraenamide

(10Z,13Z,16Z,19Z)-N-(2-hydroxyethyl)docosa-10,13,16,19-tetraenamide

C24H41NO2 (375.3137)


   

beta-Picolinyl 4-ethylisopalmitate

beta-Picolinyl 4-ethylisopalmitate

C24H41NO2 (375.3137)


   

2,3-Dihydroxy-3,7,11,15-tetramethylhexadecan-1-OL nitrate

2,3-Dihydroxy-3,7,11,15-tetramethylhexadecan-1-OL nitrate

C20H41NO5 (375.2985)


   

Lithocholate

Lithocholate

C24H39O3 (375.2899)


A bile acid anion that is the conjugate base of lithocholic acid.

   

N-(2,14-Eicosadienoyl)piperidine

N-(2,14-Eicosadienoyl)piperidine

C25H45NO (375.3501)


   

N-(1,1-dimethyl-2-hydroxy-ethyl) arachidonoyl amine

N-(1,1-dimethyl-2-hydroxy-ethyl) arachidonoyl amine

C24H41NO2 (375.3137)


   

N-ethyl N-(2-hydroxy-ethyl) arachidonoyl amine

N-ethyl N-(2-hydroxy-ethyl) arachidonoyl amine

C24H41NO2 (375.3137)


   

NA-Ala 20:4(5Z,8Z,11Z,14Z)

NA-Ala 20:4(5Z,8Z,11Z,14Z)

C23H37NO3 (375.2773)


   

NA-Amylamine 20:3(8Z,11Z,14Z)

NA-Amylamine 20:3(8Z,11Z,14Z)

C25H45NO (375.3501)


   

NA-Dopamine 15:1(9Z)

NA-Dopamine 15:1(9Z)

C23H37NO3 (375.2773)


   

NA-Histamine 18:1(9Z)

NA-Histamine 18:1(9Z)

C23H41N3O (375.3249)


   
   
   

NA-Val 18:4(6Z,9Z,12Z,15Z)

NA-Val 18:4(6Z,9Z,12Z,15Z)

C23H37NO3 (375.2773)


   

Docosatetraenoyl-EA

Docosatetraenoyl-EA

C24H41NO2 (375.3137)


   

n-[(3-methoxyphenyl)methyl]hexadecanimidic acid

n-[(3-methoxyphenyl)methyl]hexadecanimidic acid

C24H41NO2 (375.3137)


   

(2e,4e)-1-(piperidin-1-yl)icosa-2,4-dien-1-one

(2e,4e)-1-(piperidin-1-yl)icosa-2,4-dien-1-one

C25H45NO (375.3501)


   

methyl 3-[(1r,2s,3r,7s,10r,11r,13r,14s)-11-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹²]hexadecan-2-yl]propanoate

methyl 3-[(1r,2s,3r,7s,10r,11r,13r,14s)-11-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹²]hexadecan-2-yl]propanoate

C23H37NO3 (375.2773)


   

methyl 3-[(1s,2r,3r,7r,9s,14r)-9-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadecan-2-yl]propanoate

methyl 3-[(1s,2r,3r,7r,9s,14r)-9-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadecan-2-yl]propanoate

C23H37NO3 (375.2773)


   

(2e,14z)-1-(piperidin-1-yl)icosa-2,14-dien-1-one

(2e,14z)-1-(piperidin-1-yl)icosa-2,14-dien-1-one

C25H45NO (375.3501)


   

methyl 3-[(2s,3r,4r,8s,11s,12r,15r)-11-hydroxy-12,16-dimethyl-1-azapentacyclo[9.6.1.0²,¹⁵.0³,¹².0⁴,⁸]octadecan-3-yl]propanoate

methyl 3-[(2s,3r,4r,8s,11s,12r,15r)-11-hydroxy-12,16-dimethyl-1-azapentacyclo[9.6.1.0²,¹⁵.0³,¹².0⁴,⁸]octadecan-3-yl]propanoate

C23H37NO3 (375.2773)


   

methyl 3-[(1s,2r,3s,7s,8s,10s,13s,14r)-8-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹²]hexadecan-2-yl]propanoate

methyl 3-[(1s,2r,3s,7s,8s,10s,13s,14r)-8-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹²]hexadecan-2-yl]propanoate

C23H37NO3 (375.2773)


   

n-(3,5,11,18-tetrahydroxyoctadecan-2-yl)ethanimidic acid

n-(3,5,11,18-tetrahydroxyoctadecan-2-yl)ethanimidic acid

C20H41NO5 (375.2985)


   

methyl 3-{11-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹²]hexadecan-2-yl}propanoate

methyl 3-{11-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹²]hexadecan-2-yl}propanoate

C23H37NO3 (375.2773)


   

1-(piperidin-1-yl)icosa-2,4-dien-1-one

1-(piperidin-1-yl)icosa-2,4-dien-1-one

C25H45NO (375.3501)


   

methyl 3-[(1s,2r,7r)-7-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoate

methyl 3-[(1s,2r,7r)-7-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁸.0⁷,¹²]hexadecan-2-yl]propanoate

C23H37NO3 (375.2773)


   

methyl 3-{15-hydroxy-14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl}propanoate

methyl 3-{15-hydroxy-14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl}propanoate

C23H37NO3 (375.2773)


   

methyl 3-[(1s,2r,3r,7r,9s,10s,11r,13s,14r)-9-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadecan-2-yl]propanoate

methyl 3-[(1s,2r,3r,7r,9s,10s,11r,13s,14r)-9-hydroxy-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadecan-2-yl]propanoate

C23H37NO3 (375.2773)


   

(7as)-2-(hexadec-6-enoyl)-1-hydroxy-5,6,7,7a-tetrahydropyrrolizin-3-one

(7as)-2-(hexadec-6-enoyl)-1-hydroxy-5,6,7,7a-tetrahydropyrrolizin-3-one

C23H37NO3 (375.2773)


   

3-icosyl-1h-pyrrole-2-carbaldehyde

3-icosyl-1h-pyrrole-2-carbaldehyde

C25H45NO (375.3501)


   

(7z,10z,13z,16z)-n-(2-hydroxyethyl)docosa-7,10,13,16-tetraenimidic acid

(7z,10z,13z,16z)-n-(2-hydroxyethyl)docosa-7,10,13,16-tetraenimidic acid

C24H41NO2 (375.3137)


   

2-(hexadec-6-enoyl)-1-hydroxy-5,6,7,7a-tetrahydropyrrolizin-3-one

2-(hexadec-6-enoyl)-1-hydroxy-5,6,7,7a-tetrahydropyrrolizin-3-one

C23H37NO3 (375.2773)


   

6-(5,6-dimethylhept-3-en-2-yl)-3a-hydroxy-3-(2-hydroxyethyl)-5a-methyl-4h,5h,6h,7h,8h,8ah-cyclopenta[e]indol-2-one

6-(5,6-dimethylhept-3-en-2-yl)-3a-hydroxy-3-(2-hydroxyethyl)-5a-methyl-4h,5h,6h,7h,8h,8ah-cyclopenta[e]indol-2-one

C23H37NO3 (375.2773)


   

5-icosyl-1h-pyrrole-2-carbaldehyde

5-icosyl-1h-pyrrole-2-carbaldehyde

C25H45NO (375.3501)


   

methyl 3-[(1s,2s,7s,10s,13s,14r,15s)-15-hydroxy-14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl]propanoate

methyl 3-[(1s,2s,7s,10s,13s,14r,15s)-15-hydroxy-14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl]propanoate

C23H37NO3 (375.2773)


   

(3ar,5ar,6r,8ar)-6-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-3a-hydroxy-3-(2-hydroxyethyl)-5a-methyl-4h,5h,6h,7h,8h,8ah-cyclopenta[e]indol-2-one

(3ar,5ar,6r,8ar)-6-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-3a-hydroxy-3-(2-hydroxyethyl)-5a-methyl-4h,5h,6h,7h,8h,8ah-cyclopenta[e]indol-2-one

C23H37NO3 (375.2773)


   

1-(piperidin-1-yl)icosa-2,14-dien-1-one

1-(piperidin-1-yl)icosa-2,14-dien-1-one

C25H45NO (375.3501)


   

methyl 3-[(1s,2s,7r,10s,13s,14r,15s)-15-hydroxy-14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl]propanoate

methyl 3-[(1s,2s,7r,10s,13s,14r,15s)-15-hydroxy-14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl]propanoate

C23H37NO3 (375.2773)